Michael G. Grey
Chief Executive Officer, SGX PHARMACEUTICALS, INC.
Companies
- OnKure Therapeutics, Inc.Board member Oct 8, 2024 to now1
- SPRUCE BIOSCIENCES, INC.Chair Oct 8, 2020 to now2
- Mirum PharmaceuticalsBoard member Jan 2, 2020 to now3
- Horizon Therapeutics Public Ltd CoBoard member Oct 3, 2011 to Oct 6, 20234
- OnKure Therapeutics, Inc.Chair Apr 8, 2021 to Jul 27, 20235
- BioMarin PharmaceuticalBoard member Dec 18, 2006 to Mar 9, 20216
- Mirati Therapeutics, Inc.Board member Nov 6, 2014 to Jan 20, 20217
- Mirum PharmaceuticalsChair Jul 17, 2019 to Jul 24, 20198
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Mirum Pharmaceuticals MIRM93,750 shares9$7.7M at $82.39Dec 23, 2025
- OnKure Therapeutics, Inc. OKUR134,084 shares10$285.6K at $2.13Jul 27, 2023
- Horizon Therapeutics Public Ltd Co0 shares11Oct 6, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 19, 2025Sold 50,000 shares at $78.00 of Mirum Pharmaceuticals9
- Dec 19, 2025Exercised options 50,000 shares at $2.94 of Mirum Pharmaceuticals9
- Dec 1, 2025Sold 50,000 shares at $74.00 of Mirum Pharmaceuticals12
- Dec 1, 2025Exercised options 50,000 shares at $2.94 of Mirum Pharmaceuticals12
- Nov 21, 2025Sold 50,000 shares at $70.00 of Mirum Pharmaceuticals13
- Nov 21, 2025Exercised options 50,000 shares at $2.94 of Mirum Pharmaceuticals13
- Sep 27, 2024Gift 102,788 shares of Mirum Pharmaceuticals14
- Oct 6, 2023Returned to company 10,000 shares at $116.50 of Horizon Therapeutics Public Ltd Co11
- Oct 6, 2023Returned to company 48,031 shares at $116.50 of Horizon Therapeutics Public Ltd Co11
- Oct 6, 2023Returned to company 39,361 shares at $116.50 of Horizon Therapeutics Public Ltd Co11
- Sep 28, 2023Exercised options 20,000 shares at $15.96 of Horizon Therapeutics Public Ltd Co15
- Sep 14, 2023Sold 14,216 shares at $32.00 of Mirum Pharmaceuticals16
- Sep 14, 2023Exercised options 14,216 shares at $2.94 of Mirum Pharmaceuticals16
- Sep 13, 2023Sold 392 shares at $32.00 of Mirum Pharmaceuticals16
- Sep 13, 2023Exercised options 392 shares at $2.94 of Mirum Pharmaceuticals16
- Jul 26, 2023Gift 50,000 shares of OnKure Therapeutics, Inc.10
- Jun 8, 2023Sold 14,608 shares at $29.00 of Mirum Pharmaceuticals17
- Jun 8, 2023Exercised options 14,608 shares at $2.94 of Mirum Pharmaceuticals17
- May 3, 2023Sold 14,608 shares at $28.00 of Mirum Pharmaceuticals18
- May 3, 2023Exercised options 14,608 shares at $2.94 of Mirum Pharmaceuticals18
- Apr 28, 2023Exercised options 3,913 shares of Horizon Therapeutics Public Ltd Co19
- Aug 31, 2022Exercised options 50,000 shares at $1.97 of OnKure Therapeutics, Inc.20
- Apr 29, 2022Shares withheld for tax 1,139 shares at $98.56 of Horizon Therapeutics Public Ltd Co21
- Apr 29, 2022Exercised options 4,223 shares of Horizon Therapeutics Public Ltd Co21
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARSPRUCE BIOSCIENCES, INC., Chair
- 3SEC EDGARMirum Pharmaceuticals, Board member
- 4
- 5SEC EDGAROnKure Therapeutics, Inc., Chair
- 6
- 7
- 8SEC EDGARMirum Pharmaceuticals, Chair
- 9
- 10
- 11
- 12SEC EDGARForm 4 filed Dec 2, 2025
- 13SEC EDGARForm 4 filed Nov 25, 2025
- 14SEC EDGARForm 4 filed Oct 1, 2024
- 15SEC EDGARForm 4 filed Sep 28, 2023
- 16SEC EDGARForm 4 filed Sep 14, 2023
- 17SEC EDGARForm 4 filed Jun 9, 2023
- 18SEC EDGARForm 4 filed May 4, 2023
- 19SEC EDGARForm 4 filed May 2, 2023
- 20SEC EDGARForm 4 filed Sep 2, 2022
- 21SEC EDGARForm 4 filed May 2, 2022